Genmab — Juli 2020
-
God morgen.
-
Genmab
@Genmab
·
13 t
We are growing to become a fully integrated biotech company! Read a recent article by Anthony Mancini, our COO, on how we are building our commercialization teams.https://twitter.com/Genmab/status/1286330501096185859 -
AR T-cell therapies | Orva-cel infusion shows a manageable safety profile and promising clinical activity in heavily treated patients with relapsed/refractory multiple myeloma;https://multiplemyelomahub.com/medical-information/evolve-trial-can-innovative-orva-cel-technology-be-a-new-option-for-patients-with-relapsedrefractory-mm
-
Lidt voldsom start på dagen.
-
Brug vores eventuelt vores Aktiebar på Facebook.
-
Som ventet. Mega bank til pharma og biotek. Vi har prøvet det før med disse udtalelser fra politikere.
-
Men medicinal- og biotekselskaberne er jo gode nok for Trump, når de skal hjælpe med at redde hans borgere!
-
Men måske han endnu engang skulle gå gennem indkøbsforeningerne og bede dem sætte bremse på deres fee for håndtering. Måske man skulle tænke i mere køb direkte fra producenten selv i stedet for de fordyrende led. Bare en tanke...
-
@Bibob. Ja, det samme hver gang.
-
Men nu får aktierne jo så generelt en over nakken i dag..også en cocktail af genopblusning af spændingerne Trump vs Kina og en generelt hastigt faldende dollar.
-
Dem der er steget mest på kort tid falder som regel mest.
-
I situationer som denne.
-
Pharma retter sig nu. Vi mangler bare at Genmab følger med.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind